Loading clinical trials...
Loading clinical trials...
The DiRiP study will enroll patients (n = 3500) with unclear rare diseases and suspected genetic reasons. In group 1 (n = 500) subjects are clinically characterized in the context of outpatient/ inpat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Tuebingen
NCT07247279 · Rare Diseases, Generalized Myasthenia Gravis (gMG)
NCT05350761 · Cancer, Hereditary Neoplasms, and more
NCT07527624 · Rare Diseases
NCT06003153 · Genetic Predisposition, Metabolic Diseases, and more
NCT04141462 · Cancer, Genetic Predisposition
University Hospital
Tübingen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions